Cath Lab Digest

HemCon Medical Technologies Inc (Portland, Ore) announced the launch of the ChitoGauze™ dressing platform. The product represents the next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care use; it has been proven effective on severe, arterial bleeding. The initial product design received FDA 510(k) clearance in April 2009. Designed to offer the latest in battlefield care requirements, the dressing’s formulation also offers antibacterial properties, which provide medical professionals a multilayered solution to help avoid infection. Whether in the battlefield or in the ER, having an antibacterial protective layer provides an element for defense that all patients need.

For more information, visit www.hemcon.com.